Register to receive a free US Market Report Suite for Gastrointestinal Endoscopic Devices 2017 – MedSuite report synopsis and brochure
The Medical Imaging & Technology Alliance (MITA) commends Aetna for its decision to cover computed tomography (CT) colonography, also known as virtual colonoscopy.
“MITA applauds Aetna’s decision to cover CT colonography, a tool that has been proven to increase colon cancer screening rates and thereby save lives,” said Patrick Hope, Executive Director of MITA. “The best screening test is the one that gets done, and having the option of CT colonography motivates more people to get screened. This is especially important for high-risk populations, including African Americans and Latinos who are at increased risk for colon cancer. MITA has long supported expanding access to this technology and we hope to see other payers follow suit.”
Colon cancer is the second-leading cause of cancer-related deaths in the United States, despite having a 90 percent cure rate when detected early. CT colonography uses low-dose X-rays to produce three-dimensional, moving images of the colon. Compared to the traditional optical exam, CT colonography is less invasive and does not require sedation. Last year, the United States Preventive Services Task Force (USPSTF) gave CT colonography an “A” grade in its final recommendations for colorectal cancer screening, indicating that there is high certainty that its net benefit is substantial and suggesting the service should be provided to Medicare beneficiaries.
In its revised policy, Aetna now covers CTC for average‐risk members aged 50 years and older when the test is recommended by their physician. The procedure is covered by other insurance companies, including UnitedHealth Group, Anthem, Cigna and Humana, who have endorsed CT colonography as a recommended test for colorectal cancer screening
The Medical Imaging & Technology Alliance (MITA), a division of NEMA, is the collective voice of medical imaging equipment and radiopharmaceutical manufacturers, innovators and product developers. It represents companies whose sales comprise more than 90 percent of the global market for advanced medical imaging technology. For more information, visit www.medicalimaging.org. Follow MITA on Twitter @MITAToday.
For Further Information
More on the GI endoscopy market in the U.S. can be found in a series of reports published by iData Research entitled the US Market Report Suite for Gastrointestinal Endoscopic Devices 2017 – MedSuite. The suite covers reports on the following markets: GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus.
The iData report series on GI endoscopic devices covers the U.S. and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about GI market data or procedure data, register online or email us at [email protected] for a US Market Report Suite for Gastrointestinal Endoscopic Devices 2017 – MedSuite brochure and synopsis.
About iData Research
iData Research is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Ophthalmics, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Vascular Access, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Endoscopy, Anesthesiology, Wound Management, Orthopedics and more.
We have built a reputation and earned our clients’ trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
About iPolicy Search
iPolicy Search allows medical device manufacturers and reimbursement consultants to drastically reduce their research time by searching an automatically updating database of policies from over 200 insurance groups in the United States.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.